Intravenous Sodium Fluorescein Versus Oral Phenazopyridine for Ureteral Patency

NCT02757417 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study never started

Conditions

Ureteral Injury

Interventions

DRUG: sodium fluorescein
DRUG: phenazopyridine

Sponsor

University Hospitals Cleveland Medical Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]